#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	18484	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2035	899.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1406	1406	C	1100	C,A,G	998,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	33742	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3490	962.4	0	.	n	.	0	T695C	SNP	695	695	T	998	998	C	1099	C,T	989,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	33742	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3490	962.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1640	1640	A	1099	A,G	1015,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	33742	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3490	962.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2274	2274	C	1060	C	975	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	33742	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3490	962.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2348	2348	A	1045	A	972	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	33742	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3490	962.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2900	2900	C	1008	C,A,T	928,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	2316	folP	855	855	100.0	folP.l15.c4.ctg.1	1348	170.3	1	SNP	p	R229S	0	.	.	685	687	CGC	954	956	CGC	233;230;232	C;G,A;C	215;210,1;210	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6502	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3431	188.8	1	SNP	p	S91F	0	.	.	271	273	TCC	599	601	TCC	268;265;268	T;C;C	239;236;239	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6502	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3431	188.8	1	SNP	p	D95N	0	.	.	283	285	GAC	611	613	GAC	262;259;259	G;A;C	233;233;233	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6502	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3431	188.8	1	SNP	p	D95G	0	.	.	283	285	GAC	611	613	GAC	262;259;259	G;A;C	233;233;233	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	27	2038	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1416	143.5	1	SNP	p	G45D	1	.	.	133	135	GAC	478	480	GAC	244;243;240	G;A;C	216;214;216	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	988	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c30.ctg.1	1142	86.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	6278	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2949	212.0	1	SNP	p	D86N	0	.	.	256	258	GAC	582	584	GAC	271;270;272	G;A;C	248;251;253	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	6278	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2949	212.0	1	SNP	p	S88P	0	.	.	262	264	TCC	588	590	TCC	271;268;270	T;C;C	250;248;251	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5254	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2686	194.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1522	1524	GGC	258;255;255	G;G;C	237;234;235	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.43.002	penA.43.002	1	1	539	4996	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2440	203.7	0	.	p	.	0	P552L	NONSYN	1654	1656	CCG	1940	1942	CTG	208;211;211	C,G;T,C;G	172,3;158,1;163	.	.
penA.43.002	penA.43.002	1	1	539	4996	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2440	203.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1217	1219	GCA	268;272;274	G,A;C;A	243,1;245;253	penA.43.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	4996	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2440	203.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1220	1222	ATC	279;277;280	A;T;C	255;252;254	penA.43.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	4996	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2440	203.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1232	1234	GTG	281;280;280	G;T;G,T	251;252;249,1	penA.43.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	4996	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2440	203.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1232	1234	GTG	281;280;280	G;T;G,T	251;252;249,1	penA.43.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	4996	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2440	203.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1736	1738	ACC	221;219;220	A;C;C	204;206;208	penA.43.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	4996	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2440	203.7	1	SNP	p	V502P	0	.	.	1504	1506	GTG	1790	1792	GTG	250;249;251	G;T,G;G	221;196,7;221	penA.43.002:1:1:V502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	4996	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2440	203.7	1	SNP	p	A502V	1	.	.	1504	1506	GTG	1790	1792	GTG	250;249;251	G;T,G;G	221;196,7;221	penA.43.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	4996	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2440	203.7	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1913	1915	GGC	216;217;217	G;G;C,A	201;200;203,1	penA.43.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	4996	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2440	203.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1922	1924	GGC	223;215;214	G;G,T;C	203;194,1;195	penA.43.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	7144	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3118	228.1	1	SNP	p	L421P	1	L421P	NONSYN	1261	1263	CTG	1577	1579	CCG	274;273;274	C;C;G	243;245;240	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2584	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1833	140.2	0	.	p	.	0	S22G	NONSYN	64	66	AGC	311	313	GGC	174;176;175	G;G;C	160;160;157	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2584	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1833	140.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	493	493	C	194	C	175	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3378	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1528	219.9	0	.	p	.	0	G120N	NONSYN	358	360	GGC	681	683	AAC	262;261;262	A;A;C	237;237;239	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3378	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1528	219.9	0	.	p	.	0	E212G	NONSYN	634	636	GAA	957	959	GGA	278;282;284	G;G;A	261;265;264	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3378	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1528	219.9	0	.	p	.	0	Y216_S217del	DEL	646	646	T	969	969	T	284	T	267	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3378	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1528	219.9	0	.	p	.	0	D294N	NONSYN	880	882	GAT	1197	1199	AAT	291;291;293	A;A;T	272;270;272	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3378	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1528	219.9	1	SNP	p	D121N	0	.	.	361	363	GAC	684	686	GAC	266;265;266	G;A;C	240;236;239	porB1b.WHO_P_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3378	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1528	219.9	1	SNP	p	A121D	1	.	.	361	363	GAC	684	686	GAC	266;265;266	G;A;C	240;236;239	porB1b.WHO_P_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	13310	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4764	278.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1398	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1038	133.8	1	SNP	p	V57M	1	.	.	169	171	ATG	524	526	ATG	285;284;283	A;T;G	261;262;261	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
